cabergoline has been researched along with Cushing Syndrome in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Colao, A; De Martino, MC; Pivonello, C; Pivonello, R; Simeoli, C | 1 |
| Costa, MCB; Czepielewski, MA; de Melo, RB; Mattos, ACV; Rodrigues, TDC; Viecceli, C | 1 |
| Bex, M; Biller, BMK; Boguszewski, CL; Chattopadhyay, A; Feelders, RA; Fleseriu, M; González-Devia, D; Kadioglu, P; Maamari, R; Patino, H; Pedroncelli, AM; Pivonello, R; Yavuz, DG | 1 |
| Boguszewski, CL; Marques, JVO | 1 |
| Seow, CJ; Young, WF | 1 |
| Croxson, MS; Holdaway, I; Kunasegaran, S; Murphy, R | 1 |
| Biermasz, NR; Broersen, LHA; Dekkers, OM; Jha, M; Pereira, AM | 1 |
| Feelders, RA; Hofland, LJ; Lacroix, A; Newell-Price, J; Nieman, LK; Pivonello, R | 1 |
| Borson-Chazot, F; Ilie, MD; Raverot, G; Raverot, V; Tronc, F; Vasiljevic, A | 1 |
| Schteingart, DE | 1 |
| Bertrand, A; Marabelle, A; Marec-Berard, P; Raverot, G; Trouillas, J | 1 |
| Beckers, A; Petrossians, P; Thonnard, AS | 1 |
| Bruno, OD; Danilowicz, K; Manavela, MP | 1 |
| Ahmed, A; Furqan, S; Islam, N | 1 |
| Colao, A; Ferone, D; Lamberts, SW; Pivonello, R | 1 |
| Abs, R; Berwaerts, J; Mahler, C; Verhelst, J | 1 |
| Colao, A; Di Salle, F; Faggiano, A; Filippella, M; Lombardi, G; Pivonello, R | 1 |
| Defeyter, I; Rubens, R; T'Sjoen, G; Van De Saffele, J; Vandeweghe, M | 1 |
7 review(s) available for cabergoline and Cushing Syndrome
| Article | Year |
|---|---|
The dopaminergic control of Cushing's syndrome.
Topics: Adrenal Gland Neoplasms; Cabergoline; Cushing Syndrome; Humans; Hydrocortisone; Pituitary ACTH Hypersecretion; Pituitary Diseases; Pituitary Neoplasms | 2022 |
Medical therapy in severe hypercortisolism.
Topics: Cabergoline; Cushing Syndrome; Humans; Ketoconazole; Metyrapone; Mitotane | 2021 |
Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.
Topics: Cabergoline; Cushing Syndrome; Dopamine Agonists; Humans; Hydrocortisone; Mitotane; Treatment Outcome | 2018 |
Advances in the medical treatment of Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenal Gland Neoplasms; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cabergoline; Cushing Syndrome; Dopamine Agonists; ErbB Receptors; Gefitinib; Hormones; Humans; Imidazoles; Isoquinolines; Molecular Targeted Therapy; Pituitary ACTH Hypersecretion; Pyrazoles; Pyridines; Receptors, Glucocorticoid; Roscovitine; Somatostatin; Temozolomide; Tretinoin | 2019 |
Drugs in the medical treatment of Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Antiparkinson Agents; Cabergoline; Cushing Syndrome; Ergolines; Human Growth Hormone; Humans; Hydrocortisone; Ketoconazole; Metyrapone; Pituitary Hormones; Pituitary Neoplasms | 2009 |
Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline.
Topics: Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Humans | 2010 |
Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature.
Topics: Adult; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Ketoconazole; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 1999 |
1 trial(s) available for cabergoline and Cushing Syndrome
| Article | Year |
|---|---|
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.
Topics: Cabergoline; Cushing Syndrome; Humans; Hydrocortisone; Pituitary ACTH Hypersecretion; Treatment Outcome | 2023 |
10 other study(ies) available for cabergoline and Cushing Syndrome
| Article | Year |
|---|---|
Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Topics: Cabergoline; Cushing Syndrome; Humans; Hydrocortisone; Hypokalemia; Ketoconazole; Pituitary ACTH Hypersecretion; Retrospective Studies | 2022 |
An Overlooked Cause of Hypokalemia.
Topics: 14-alpha Demethylase Inhibitors; Adenoma; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Hypokalemia; Ketoconazole; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Neoplasms | 2017 |
An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents; Cabergoline; Cushing Syndrome; Ergolines; Humans; Male; Pituitary Neoplasms; Prolactinoma; Young Adult | 2017 |
Cabergoline in severe ectopic or occult Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Dopamine Agonists; Female; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Intraductal Neoplasms; Rectal Neoplasms; Steroid Synthesis Inhibitors; Thymus Neoplasms; Treatment Outcome | 2019 |
Cabergoline therapy of paraneoplastic Cushing syndrome in children.
Topics: Adolescent; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Kidney Neoplasms; Paraneoplastic Syndromes; Wilms Tumor | 2010 |
Macrocorticotropinoma shrinkage and control of hypercortisolism under long-term cabergoline therapy: case report.
Topics: Adult; Cabergoline; Cushing Syndrome; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary ACTH Hypersecretion | 2012 |
Disappearance of pituitary macro adenoma with combination of ketoconazole and cabergoline treatment: an unusual case of Cushing's syndrome with interesting findings.
Topics: 14-alpha Demethylase Inhibitors; Adenoma; Adult; Antineoplastic Agents; Cabergoline; Cushing Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Ergolines; Humans; Ketoconazole; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Severity of Illness Index; Tomography, X-Ray Computed | 2012 |
Cabergoline plus lanreotide for ectopic Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adult; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Drug Therapy, Combination; Ergolines; Humans; Lung Neoplasms; Male; Peptides, Cyclic; Somatostatin | 2005 |
Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.
Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Humans; Magnetic Resonance Imaging; Male; Nelson Syndrome; Pituitary Neoplasms; Remission Induction | 1999 |
Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Cabergoline; Cushing Syndrome; Dexamethasone; Ergolines; Glucocorticoids; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin-Releasing Hormone; Treatment Outcome | 2002 |